CHESPRO
Overview:
Chespro is a beta-blocker containing Metoprolol, available in extended-release (ER) tablets of 25 mg and 50 mg. Metoprolol is a selective beta-1 adrenergic receptor blocker that is primarily used to manage hypertension (high blood pressure), angina (chest pain), and improve outcomes after a heart attack. The extended-release formulation of Chespro ensures a consistent and sustained effect, allowing for once-daily administration. By decreasing the heart rate and reducing the workload on the heart, Metoprolol helps in preventing cardiac events, managing arrhythmias, and improving overall cardiovascular health.
- Class
- Dosage
- Indications
- Mechanism of action
Beta-blocker
Hypertension:
Initial Dose: 25 mg to 50 mg once daily.
Maintenance Dose: 50 mg to 100 mg once daily, adjusted based on individual patient response and clinical condition.
Angina Pectoris: 25 mg to 50 mg once daily.
Post-Myocardial Infarction:
Initial Dose: 25 mg once daily, may increase depending on tolerance and clinical response.
Maintenance Dose: 50 mg to 100 mg once daily.
Heart Failure:
Initial Dose: 25 mg once daily, titrated upward based on patient tolerance and response.
Maintenance Dose: 50 mg once daily or as directed by a healthcare provider.
Arrhythmias:
Dosage will be determined by a healthcare provider based on the specific type and severity of arrhythmia.
- Essential Hypertension: For the treatment of high blood pressure to help reduce the risk of heart attack, stroke, and other cardiovascular diseases.
- Angina Pectoris: To manage chest pain related to reduced blood flow to the heart.
- Post-Myocardial Infarction: For improving survival and reducing complications after a heart attack.
- Chronic Heart Failure: To manage symptoms and improve heart function in patients with heart failure.
- Arrhythmias: For the management of abnormal heart rhythms.
Metoprolol works by selectively blocking the beta-1 adrenergic receptors in the heart. This leads to a reduction in heart rate, contractility, and cardiac output, ultimately lowering blood pressure and reducing the heart’s oxygen demand. It also helps to stabilize heart rhythms, making it effective in treating arrhythmias. The extended-release formulation provides a sustained therapeutic effect, allowing for consistent blood levels of Metoprolol, ensuring better management of conditions with a single daily dose.
